Lunesta Goes Into Review

By SuperSpy 

Sepracor, a research-based pharmaceutical company, has put it’s account for its Lunesta sleep aid up for review. The incumbent, McCann HumanCare, is going to defend against three or four undisclosed shops.

Adweek is estimating the company’s media spending around $330 million last year and totaled nearly $250 million this year alone. They also think that media duties, at IPG’s Initiative, are not in play.

Advertisement

Advertisement